Preventive sublingual immunotherapy in preschool children: First evidence for safety and pro-tolerogenic effects

Pediatric Allergy and Immunology

Volumn 25, Issue 8, 2014, Pages 788-795

  Szépfalusi, Zsolt ^a   Bannert, Christina ^a   Ronceray, Leila ^a   Mayer, Elisabeth ^a   Hassler, Michaela ^a   Wissmann, Eva ^a   Dehlink, Eleonora ^a   Gruber, Saskia ^a   Graf, Alexandra ^a   Lupinek, Christian ^a   Valenta, Rudolf ^a   Eiwegger, Thomas ^a   Urbanek, Radvan ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Allergen specific immunotherapy; Allergy prevention; IgE sensitization; Skin prick test; Specific IgE

Indexed keywords

GRASS POLLEN EXTRACT; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN 10; PLACEBO; TRANSFORMING GROWTH FACTOR BETA; ALLERGEN;

ALLERGY RAPID TEST; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; GRASS POLLEN; HOUSE DUST; HUMAN; IN VITRO STUDY; LYMPHOCYTE FUNCTION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PILOT STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; SENSITIZATION; SKIN TEST; SUBLINGUAL IMMUNOTHERAPY; UPREGULATION; ANIMAL; ASYMPTOMATIC DISEASE; BLOOD; CELL CULTURE; CELL PROLIFERATION; DESENSITIZATION; HYPERSENSITIVITY; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; POACEAE; POLLEN; PROCEDURES; PYROGLYPHIDAE; SUBLINGUAL DRUG ADMINISTRATION;

ADMINISTRATION, SUBLINGUAL; ALLERGENS; ANIMALS; ANTIGENS, DERMATOPHAGOIDES; ASYMPTOMATIC DISEASES; CELL PROLIFERATION; CELLS, CULTURED; CHILD, PRESCHOOL; DESENSITIZATION, IMMUNOLOGIC; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERSENSITIVITY; IMMUNE TOLERANCE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION; MALE; PILOT PROJECTS; PLACEBOS; POACEAE; POLLEN; PROSPECTIVE STUDIES; PYROGLYPHIDAE; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 84922546566     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/pai.12310     Document Type: Article

References (31)

1. Marogna M, Bruno M, Massolo A, Falagiani P. Long-lasting effects of sublingual immunotherapy for house dust mites in allergic rhinitis with bronchial hyperreactivity: a long-term (13-year) retrospective study in real life. Int Arch Allergy Immunol 2007: 142: 70-8.
2. Di Rienzo V, Marcucci F, Puccinelli P, et al. Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study. Clin Exp Allergy 2003: 33: 206-10.
3. Eng PA, Reinhold M, Gnehm HP. Long-term efficacy of preseasonal grass pollen immunotherapy in children. Allergy 2002: 57: 306-12.
4. Durham SR, Walker SM, Varga EM, et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999: 341: 468-75.
5. Akdis M, Akdis CA. Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol 2007: 119: 780-91.
6. Larche M, Akdis CA, Valenta R. Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol 2006: 6: 761-71.
7. Purello-D'Ambrosio F, Gangemi S, Merendino RA, et al. Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study. Clin Exp Allergy 2001: 31: 1295-302.
8. Des Roches A, Paradis L, Menardo JL, Bouges S, Daures JP, Bousquet J. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol 1997: 99: 450-3.
9. Pajno GB, Barberio G, De Luca F, Morabito L, Parmiani S. Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy 2001: 31: 1392-37.
10. Jacobsen L, Niggemann B, Dreborg S, et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 2007: 62: 943-8.
11. Inal A, Altintas DU, Yilmaz M, Karakoc GB, Kendirli SG, Sertdemir Y. Prevention of new sensitizations by specific immunotherapy in children with rhinitis and/or asthma monosensitized to house dust mite. J Investig Allergol Clin Immunol 2007: 17: 85-91.
12. Kinaciyan T, Jahn-Schmid B, Radakovics A, et al. Successful sublingual immunotherapy with birch pollen has limited effects on concomitant food allergy to apple and the immune response to the Bet v 1 homolog Mal d 1. J Allergy Clin Immunol 2007: 119: 937-43.
13. Bohle B, Kinaciyan T, Gerstmayr M, Radakovics A, Jahn-Schmid B, Ebner C. Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation. J Allergy Clin Immunol 2007: 120: 707-13.
14. Lupinek C, Wollmann E, Baar A, et al. Advances in allergen-microarray technology for diagnosis and monitoring of allergy: the MeDALL allergen-chip. Methods 2013: 66: 106-119.
15. Eng PA, Borer-Reinhold M, Heijnen IA, Gnehm HP. Twelve-year follow-up after discontinuation of preseasonal grass pollen immunotherapy in childhood. Allergy 2006: 61: 198-201.
16. Holt PG, Sly PD, Sampson HA, et al. Prophylactic use of sublingual allergen immunotherapy in high-risk children: a pilot study. J Allergy Clin Immunol 2013: 132: 991-3.e1.
17. Hoyne GF, Askonas BA, Hetzel C, Thomas WR, Lamb JR. Regulation of house dust mite responses by intranasally administered peptide: transient activation of CD4+ T cells precedes the development of tolerance in vivo. Int Immunol 1996: 8: 335-42.
18. Holt PG, Rowe J, Kusel M, et al. Toward improved prediction of risk for atopy and asthma among preschoolers: a prospective cohort study. J Allergy Clin Immunol 2010: 125: 653-9, 59.e1-59.e7.
19. Durham SR, Emminger W, Kapp A, et al. SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial. J Allergy Clin Immunol 2012: 129: 717-25.e5.
20. Akdis CA, Akdis M. Mechanisms and treatment of allergic disease in the big picture of regulatory T cells. J Allergy Clin Immunol 2009: 123: 735-46; quiz 47-8.
21. James LK, Shamji MH, Walker SM, et al. Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies. J Allergy Clin Immunol 2011: 127: 509-16.e1-5.
22. Dehlink E, Eiwegger T, Gerstmayr M, et al. Absence of systemic immunologic changes during dose build-up phase and early maintenance period in effective specific sublingual immunotherapy in children. Clin Exp Allergy 2006: 36: 32-9.
23. Bonvalet M, Moussu H, Wambre E, et al. Allergen-specific CD4+ T cell responses in peripheral blood do not predict the early onset of clinical efficacy during grass pollen sublingual immunotherapy. Clin Exp Allergy 2012: 42: 1745-55.
24. von Mutius E. Infection: friend or foe in the development of atopy and asthma? The epidemiological evidence. Eur Respir J 2001: 18: 872-81.
25. Prescott SL, Smith P, Tang M, et al. The importance of early complementary feeding in the development of oral tolerance: concerns and controversies. Pediatr Allergy Immunol 2008: 19: 375-80.
26. Ege MJ, Mayer M, Normand AC, et al. Exposure to environmental microorganisms and childhood asthma. N Engl J Med 2011: 364: 701-9.
27. Vrtala S, Akdis CA, Budak F, et al. T cell epitope-containing hypoallergenic recombinant fragments of the major birch pollen allergen, Bet v 1, induce blocking antibodies. J Immunol 2000: 165: 6653-9.
28. Baron-Bodo V, Horiot S, Lautrette A, et al. Heterogeneity of antibody responses among clinical responders during grass pollen sublingual immunotherapy. Clin Exp Allergy 2013: 43: 1362-73.
29. Selb R, Eckl-Dorna J, Vrtala S, Valenta R, Niederberger V. An assay that may predict the development of IgG enhancing allergen-specific IgE binding during birch immunotherapy. Allergy 2013: 68: 1199-202.
30. Hopper JL, Bui QM, Erbas B, et al. Does eczema in infancy cause hay fever, asthma, or both in childhood? Insights from a novel regression model of sibling data. J Allergy Clin Immunol 2012: 130: 1117-22.e1.
31. Shamji MH, Durham SR. Mechanisms of immunotherapy to aeroallergens. Clin Exp Allergy 2011: 41: 1235-46.